Today, an individual has a heart attack every 34 seconds, and someone dies of a heart-disease-related event every minute. Coronary heart disease alone costs the United States $109 billion dollars each year. Worldwide, cardiovascular disease (CVD) accounted for 17.3 million deaths in 2008 and is predicted to rise to 23.3 million by 2030.
In short, this technology has the potential to bring about a revolution in every area of cardiovascular care, as well as other specialties yet to be identified. At this time, it is difficult to accurately quantify the size of the market for this device. However, in view of the high cost of cardiovascular care highlighted earlier, it is confidently believed that a multibillion dollar global market exists for the product, with revenue models derived from a combination of device sales and annual licensing fees to provide recurring revenue.